$RichWire Markets and money, explained simply

LIVE

03:39 Tenon Medical Details Third-Quarter 2026 Financial Results 03:38 Grown Rogue International Reports Q3 2026 Financial Results 03:29 Applied Materials Holds Q4 2026 Earnings Call 03:19 Intrusion Inc. Holds Third Quarter 2026 Earnings Call 03:09 Intellinetics Details Financial Results During Third Quarter 2026 Earnings Call 03:09 Shimmick Corporation Reports Third Quarter 2026 Financial Results 02:59 Garmin Valuation Concerns: Fundamentals Outpace Stock Price Above $200 02:44 Nvidia Alters Singapore Revenue Reporting Amid Megaspeed Scrutiny and Leadership Shakeup 02:38 Legacy Education Reports First Quarter Fiscal 2027 Results 02:36 American Electric Power Unveils $100 Billion Five-Year Plan to Meet Surging Electricity Demand 02:30 Consumer Staples in Focus: Comparing Chipotle and Coca-Cola Amid Tech Volatility 02:19 Freelancer Details Platform Scale and Revenue Breakdown at Investor Event 03:39 Tenon Medical Details Third-Quarter 2026 Financial Results 03:38 Grown Rogue International Reports Q3 2026 Financial Results 03:29 Applied Materials Holds Q4 2026 Earnings Call 03:19 Intrusion Inc. Holds Third Quarter 2026 Earnings Call 03:09 Intellinetics Details Financial Results During Third Quarter 2026 Earnings Call 03:09 Shimmick Corporation Reports Third Quarter 2026 Financial Results 02:59 Garmin Valuation Concerns: Fundamentals Outpace Stock Price Above $200 02:44 Nvidia Alters Singapore Revenue Reporting Amid Megaspeed Scrutiny and Leadership Shakeup 02:38 Legacy Education Reports First Quarter Fiscal 2027 Results 02:36 American Electric Power Unveils $100 Billion Five-Year Plan to Meet Surging Electricity Demand 02:30 Consumer Staples in Focus: Comparing Chipotle and Coca-Cola Amid Tech Volatility 02:19 Freelancer Details Platform Scale and Revenue Breakdown at Investor Event

Topic: Zelsuvmi

Pelthos Therapeutics Reports 114% Surge in Third-Quarter Revenue

🧠AI Analysis

AI Analysis1 h ago

Pelthos Therapeutics Reports 114% Surge in Third-Quarter Revenue

Pelthos Therapeutics announced a 114% year-over-year jump in net product revenue for Zelsuvmi during the third quarter of 2026, alongside plans for portfolio expansion an…

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.